Business & Consumer Services » Business Services | Syngene International Ltd.

Syngene International Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
6,871
8,427
11,070
11,924
13,494
Cost of Goods Sold (COGS) incl. D&A
4,624
5,437
7,173
8,306
9,941
Gross Income
2,247
2,990
3,897
3,618
3,553
SG&A Expense
413
979
846
934
1,316
EBIT
1,823
1,985
-
-
2,000
Unusual Expense
-
-
2
-
-
Non Operating Income/Expense
282
129
150
479
1,709
Interest Expense
4
79
84
175
227
Pretax Income
1,566
2,035
2,810
3,465
3,725
Income Tax
218
285
402
592
671
Consolidated Net Income
1,348
1,750
2,408
2,873
3,054
Net Income
1,348
1,750
2,408
2,873
3,054
Net Income After Extraordinaries
1,348
1,750
2,408
2,873
3,054
Net Income Available to Common
1,348
1,750
2,408
2,873
3,054
EPS (Basic)
6.74
8.79
12.39
14.71
15.42
Basic Shares Outstanding
200
199
194
195
198
EPS (Diluted)
6.74
8.79
12.19
14.55
15.37
Diluted Shares Outstanding
200
199
198
197
199
EBITDA
2,479
2,799
4,014
3,803
3,314
Other Operating Expense
11
26
10
24
237
Non-Operating Interest Income
29
-
1
501
243

About Syngene International

View Profile
Address
Biocon Park , Plot 2&3, Phase-IV
Bangalore Karnataka 560099
India
Employees -
Website http://www.syngeneintl.com
Updated 09/14/2018
Syngene International Ltd. operates as a contract research organization, which provides discovery and development services for novel molecular entities. Its services include discovery chemistry, discovery biology, safety assessment, large molecule development, chemical development, formulation development, stability studies, polymer research, integrated discovery and development, and clinical development. The company was founded on November 18, 1993 and is headquartered in Bangalore, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.